Press Releases April 30, 2026 08:00 AM

Nature’s Sunshine Appoints John Hnanicek as Chief Technology Officer

Nature's Sunshine appoints seasoned technology executive John Hnanicek as CTO to drive digital innovation and growth

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
NATR

Nature's Sunshine Products, Inc., a NASDAQ-listed leader in herbal and nutritional supplements, announced the appointment of John Hnanicek as Chief Technology Officer effective May 4, 2026. Hnanicek brings extensive experience in technology leadership and digital transformation from previous roles at Melaleuca and The Vitamin Shoppe, aiming to modernize technology platforms and enhance customer experiences to support the company's growth strategy.

Nature’s Sunshine Appoints John Hnanicek as Chief Technology Officer
NATR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • John Hnanicek appointed CTO to lead technology modernization and digital innovation.
  • Extensive technology and e-commerce experience from roles at Melaleuca, The Vitamin Shoppe, and other companies.
  • Focus on enhancing customer and consultant experiences and supporting long-term growth through advanced technology.

LEHI, Utah, April 30, 2026 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (NASDAQ: NATR) (“Nature’s Sunshine”) (the “Company”), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, today announced that John Hnanicek has been appointed Chief Technology Officer, effective May 4, 2026.

Mr. Hnanicek brings decades of senior leadership experience in technology, digital innovation, and e-commerce transformation across leading consumer, retail, and direct-to-consumer organizations. He most recently served as Chief Digital Innovation Officer at Melaleuca, where he led enterprise-wide digital initiatives, technology modernization, and customer innovation efforts.

“We are excited to welcome John to Nature’s Sunshine’s executive team,” said Ken Romanzi, Chief Executive Officer. “John brings a rare combination of deep technical expertise, digital innovation leadership, and operational experience that will be critical as we continue to modernize our technology platforms, enhance the customer and consultant experience, and support our long-term growth strategy.”

Prior to Melaleuca, Mr. Hnanicek held senior technology and innovation leadership roles at The Vitamin Shoppe, where he served as Chief Customer Innovation and Technology Officer and Chief Information Officer, leading enterprise technology, digital commerce, and customer engagement initiatives. Earlier in his career, he served as SVP and Chief Information Officer at Charming Charlie and held executive technology leadership roles at organizations including Altrec.com, Knowledge Learning Corporation, Paciolan, Inc., eToys, Hollywood Entertainment, and OfficeMax.

Throughout his career, Mr. Hnanicek has demonstrated a strong track record of leading large-scale digital transformations, modernizing enterprise systems, and enabling growth through technology, data, and innovation. He holds a Bachelor of Science in Computer Science from Cleveland State University.

“I am honored to join Nature’s Sunshine, a company with a strong mission and global reach,” said Mr. Hnanicek. “I look forward to working with the leadership team to advance the Company’s technology capabilities, accelerate digital innovation, and support Nature’s Sunshine’s vision for growth.”

About Nature’s Sunshine Products

Nature’s Sunshine Products (Nasdaq: NATR), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, distributes its products in more than 40 countries worldwide. Additional information about the Company can be obtained at its website, www.naturessunshine.com. 

Investor Relations:

Gateway Group, Inc.
Cody Slach
1-949-574-3860
NATR@gateway-grp.com


Risks

  • Execution risk related to the successful modernization of technology platforms.
  • Potential integration challenges within the company's existing systems and culture during digital transformation.
  • Dependence on the CTO's ability to accelerate innovation to meet competitive pressures.

More from Press Releases

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026 Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026